ACTA1 and Hepatic fibrosis: Wu et al. discovered that carvedilol retarded the cell cycle at the G0/G1 phase and decreased the α-SMA expression and collagen I/III deposition to inhibit the proliferation of HSC induced by Ang II, thereby ameliorating hepatic fibrosis.